Harford Simon N.R.
Insider CIK 1443705 · FOLD Chief Financial Officer · ALBO CFO and Treasurer · PRXL See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FOLD AMICUS THERAPEUTICS, INC. | D To issuer deriv | 2026-04-27 | 2026-04-27 | 150,517 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | D To issuer deriv | 2026-04-27 | 2026-04-27 | 189,043 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | D To issuer deriv | 2026-04-27 | 2026-04-27 | 99,073 | — | $0 | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | D To issuer | 2026-04-27 | 2026-04-27 | 143,595 | $14.50 | $2.08M | 0 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | F Tax w/h | 2025-12-26 | 2025-12-30 | 71,303 | $14.25 | $1.02M | 143,595 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | F Tax w/h | 2025-08-21 | 2025-08-25 | 12,529 | $7.60 | $95.2K | 214,898 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award deriv | 2025-01-03 | 2025-01-06 | 150,517 | — | $0 | 150,517 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award | 2025-01-03 | 2025-01-06 | 83,073 | — | $0 | 227,427 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | F Tax w/h | 2025-01-02 | 2025-01-06 | 7,482 | $9.31 | $69.7K | 144,354 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | F Tax w/h | 2024-08-21 | 2024-08-23 | 12,529 | $12.09 | $151.5K | 151,836 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award deriv | 2024-01-02 | 2024-01-04 | 99,073 | — | $0 | 99,073 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award | 2024-01-02 | 2024-01-04 | 57,392 | — | $0 | 164,365 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award deriv | 2023-08-21 | 2023-08-23 | 189,043 | — | $0 | 189,043 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award | 2023-08-21 | 2023-08-23 | 106,973 | — | $0 | 106,973 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 23,700 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 73,950 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 37,500 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 31,500 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 31,500 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | U Tender | 2023-03-02 | 2023-03-02 | 13,739 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2023-01-23 | 2023-01-23 | 102 | $43.80 | $4.5K | 32,689 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2023-01-19 | 2023-01-20 | 1,776 | $43.80 | $77.8K | 32,791 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award | 2023-01-19 | 2023-01-25 | 55,000 | — | $0 | 87,689 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award | 2023-01-19 | 2023-01-27 | 55,000 | — | $0 | 87,689 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-10-24 | 2022-10-25 | 104 | $19.58 | $2.0K | 33,295 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-10-11 | 2022-10-13 | 80 | $23.79 | $1.9K | 33,399 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-07-22 | 2022-07-25 | 106 | $24.67 | $2.6K | 33,479 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-07-12 | 2022-07-13 | 95 | $24.03 | $2.3K | 33,585 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-04-22 | 2022-04-25 | 103 | $32.92 | $3.4K | 33,680 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-04-11 | 2022-04-11 | 96 | $35.74 | $3.4K | 33,783 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-01-24 | 2022-01-25 | 416 | $24.88 | $10.4K | 33,879 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award | 2022-01-18 | 2022-01-20 | 21,600 | — | $0 | 34,295 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-01-11 | 2022-01-11 | 111 | $25.95 | $2.9K | 12,695 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2021-10-11 | 2021-10-12 | 93 | $30.23 | $2.8K | 12,614 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2021-07-13 | 2021-07-15 | 98 | $35.02 | $3.4K | 12,707 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2021-04-12 | 2021-04-14 | 92 | $32.12 | $3.0K | 12,196 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2021-01-21 | 2021-01-25 | 23,700 | — | $0 | 23,700 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award | 2021-01-21 | 2021-01-25 | 5,500 | — | $0 | 10,114 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2021-01-11 | 2021-01-13 | 110 | $37.33 | $4.1K | 4,614 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2021-01-11 | 2021-01-25 | 110 | $37.33 | $4.1K | 4,614 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2020-10-12 | 2020-10-13 | 90 | $37.30 | $3.4K | 4,616 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2020-07-10 | 2020-07-10 | 92 | $25.56 | $2.4K | 4,706 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2020-04-13 | 2020-04-13 | 97 | $16.52 | $1.6K | 4,798 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2020-01-21 | 2020-01-23 | 31,500 | — | $0 | 31,500 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2020-01-10 | 2020-01-14 | 105 | $27.20 | $2.9K | 4,895 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2019-01-22 | 2019-01-24 | 31,500 | — | $0 | 31,500 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2018-10-10 | 2018-10-12 | 37,500 | — | $0 | 37,500 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award | 2018-10-10 | 2018-10-12 | 5,000 | — | $0 | 5,000 | SEC↗ |
| PRXL PAREXEL INTERNATIONAL CORP | U Tender deriv | 2017-09-29 | 2017-10-04 | 44,028 | $14.13 | $622.1K | 0 | SEC↗ |
| PRXL PAREXEL INTERNATIONAL CORP | D To issuer | 2017-09-29 | 2017-10-04 | 10,736 | — | $0 | 0 | SEC↗ |
| PRXL PAREXEL INTERNATIONAL CORP | A Award deriv | 2017-05-09 | 2017-05-10 | 44,028 | — | $0 | 44,028 | SEC↗ |
| PRXL PAREXEL INTERNATIONAL CORP | A Award | 2017-05-09 | 2017-05-10 | 10,736 | — | $0 | 10,736 | SEC↗ |